![Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine](https://www.frontiersin.org/files/Articles/733538/fmed-08-733538-HTML/image_m/fmed-08-733538-g001.jpg)
Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine
![Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine](https://www.frontiersin.org/files/Articles/733538/fmed-08-733538-HTML/image_m/fmed-08-733538-g002.jpg)
Frontiers | Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study | Medicine
![Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/809457/fcell-09-809457-HTML/image_m/fcell-09-809457-g001.jpg)
Frontiers | Ferroptosis Signaling and Regulators in Atherosclerosis | Cell and Developmental Biology
![Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/183a244c-c39e-455c-8181-7b3a8eb0ff37/fx1_lrg.jpg)
Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions - The Journal of Allergy and Clinical Immunology: In Practice
IRCCS Ospedale San Raffaele - AL SAN RAFFAELE LO EUROPEAN CIVIC PRIZE ON CHRONIC PAIN PER L'INNOVAZIONE NEL TRATTAMENTO DEL DOLORE CRONICO Occuparsi delle persone con dolore cronico a 360°, valutandole in
![Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial - The ... Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial - The ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3385f8f4-4d20-4c33-beb5-5a603fcf977e/gr1.gif)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial - The ...
![First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis - Annals of Oncology First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/10580d0c-6f07-4c8c-b5cf-7fe8d79fd9e5/gr1_lrg.jpg)